Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Databases
Publications
All →
12 November 2025
Development of medical device policies, 2nd ed.
A first edition of the Development of Medical Devices Policies was published in 2011. This second edition was prepared to reflect the transition from the...
6 October 2025
Improving access to assistive technology in United Republic of Tanzania (2022-2023): project report
The report summarizes a collaboration between the Ministry of Health of the United Republic of Tanzania, HelpAge Tanzania and the World Health Organization...
5 October 2025
Enabling rapid access to essential assistive technology in Ukraine (2022-2023): project report
This report summarizes a collaboration between the Ministry of Health of Ukraine and the World Health Organization (WHO) in 2022 and 2023. The goal was...
3 October 2025
WHO Drug Information - Volume 39, No. 3
The Third issue of volume 39 for 2025 includes:Consultation Documents: Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum) Cefiderocol powder...
Journal articles
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines: Geneva, Switzerland, December 2019
npj Vaccines 5, 52 (2020)
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71
Vaccine, Volume 38, Issue 32, 6 July 2020, Pages 4917-4923
Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards
PLoS neglected tropical diseases vol. 4,11 e890. 16 Nov. 2010